Reverse transcriptase-IN-1
CAS No. 2380001-43-2
Reverse transcriptase-IN-1 ( —— )
产品货号. M26414 CAS No. 2380001-43-2
Reversetranscriptase-IN-1 是一种二芳基苯并嘧啶 (DABP) 类似物,是 HIV-1 非核苷类逆转录酶的有效抑制剂,IC50 为 13.7 nM。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 5MG | ¥1798 | 有现货 |
|
| 10MG | ¥2608 | 有现货 |
|
| 25MG | ¥4431 | 有现货 |
|
| 50MG | ¥6383 | 有现货 |
|
| 100MG | ¥8748 | 有现货 |
|
| 500MG | ¥17658 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Reverse transcriptase-IN-1
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Reversetranscriptase-IN-1 是一种二芳基苯并嘧啶 (DABP) 类似物,是 HIV-1 非核苷类逆转录酶的有效抑制剂,IC50 为 13.7 nM。
-
产品描述Reverse transcriptase-IN-1 is a diarylbenzopyrimidine (DABP) analogue and a potent inhibitor of HIV-1 nonnucleoside reverse transcriptase with an IC50of 13.7 nM. (In Vitro):Reverse transcriptase-IN-1 has antiviral activity with EC50 values of 3.4 nM, 4.3 nM and 3.6 nM for HIV-1 IIIB, E138K and K103N mutants, respectively.(In Vivo):The PK study and safety assessment of Reverse transcriptase-IN-1 shows that it is absorbed with mean residence times (MRTs) of 11.8 hours (5 mg/kg, p.o.) and 11.4 hours (1 mg/kg, i.v.) at these two doses. The Cmax of Reverse transcriptase-IN-1 is 39.9 ng/mL at a dose of 5 mg/kg. The oral bioavailability of Reverse transcriptase-IN-1 is significantly improved to 16.5% at a dose of 5 mg/kg in rats. The intrinsic rat microsome clearance of Reverse transcriptase-IN-1 is 33.2 μL/min/mg proteins.
-
体外实验——
-
体内实验The oral bioavailability of Reverse transcriptase-IN-1 (Compound 12z) is significantly improved to 16.5% at a dose of 5 mg/kg in rats. The intrinsic rat microsome clearance of Reverse transcriptase-IN-1 is 33.2 μL/min/mg proteins. The PK study and safety assessment of Reverse transcriptase-IN-1 shows that it is absorbed with mean residence times (MRTs) of 11.8 hours (5 mg/kg, p.o.) and 11.4 hours (1 mg/kg, i.v.) at these two doses. The Cmax of Reverse transcriptase-IN-1 is 39.9 ng/mL at a dose of 5 mg/kg. A single-dose toxicity test of Reverse transcriptase-IN-1 in rats shows no mortality, and there is no abnormal body weight decrease in the animals in the week following an intragastrical dose at 293 mg/kg body weigh. The above results indicate that Reverse transcriptase-IN-1 could be an orally bioavailable candidate for human HIV-1 infection research.
-
同义词——
-
通路Microbiology/Virology
-
靶点HIV
-
受体——
-
研究领域——
-
适应症——
化学信息
-
CAS Number2380001-43-2
-
分子量447.458
-
分子式C25H17N7O2
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 12.5 mg/mL (27.94 mM)
-
SMILESCc1cc(\C=C\C#N)cc(c1Nc1nc(Nc2ccc(cc2)C#N)nc2ccccc12)[N+]([O-])=O
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1.Atta-ur-Rahman, et, al. Antifungal aryltetralin lignans from leaves of Podophyllum hexandrum. Phytochemistry. 1995 Sep; 40(2): 427-431.
产品手册
关联产品
-
4-Chloro-2-(trifluor...
4-Chloro-2-(三氟乙酰基)苯胺盐酸盐是 HIV-1 RT(HIV 逆转录酶)的抑制剂。
-
Ditiocarb sodium
二硫威钠(二乙基二硫代氨基甲酸钠)是铜胶结速率的促进剂。二乙基二硫代氨基甲酸钠可降低艾滋病毒感染的发生率。
-
YIR-819 TFA salt
YIR-819 是一种小分子 CD4 模拟物,可作为高效的 HIV 进入抑制剂,针对 YTA48P 病毒的 IC50 为 2.6 uM,没有明显的细胞毒性 (CC50=33 uM)。
021-51111890
购物车()
sales@molnova.cn

